21 research outputs found
Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma
Fashionably Late? Building up the Milky Way's Inner Halo
Using a sample of 248 metal-poor stars (RR Lyraes, red giants and RHB stars)
which is remarkable for the accuracy of its 6-D kinematical data, we find a new
component for the local halo which has an axial ratio c/a ~ 0.2, a similar
flattening to the thick disk. It has a small prograde rotation but is supported
by velocity anisotropy, and contains more intermediate-metallicity stars (with
-1.5 < [Fe/H] < -1.0) than the rest of our sample. We suggest that this
component was formed quite late, during or after the formation of the disk. It
formed either from the gas that was accreted by the last major mergers
experienced by the Galaxy, or by dynamical friction of massive infalling
satellite(s) with the halo and possibly the stellar disk or thick disk. The
remainder of the stars in our sample exhibit a clumpy distribution in energy
and angular momentum, suggesting that the early, chaotic conditions under which
the inner halo formed were not violent enough to erase the record of their
origins. The clumpy structure suggests that a relatively small number of
progenitors were responsible for building up the inner halo, in line with
theoretical expectations. We find a difference in mean binding energy between
the RR Lyrae variables and the red giants in our sample, suggesting that more
of the RR Lyraes in the sample belong to the outer halo, and that the outer
halo may be somewhat younger, as first suggested by Searle and Zinn (1978). We
also find that the RR Lyrae mean rotation is more negative than the red giants,
which is consistent with the recent result of Carollo et al.(2007) that the
outer halo has a retrograde rotation and with the difference in kinematics seen
between RR Lyraes and BHB stars by Kinman et al.(2007).Comment: 16 pages, 10 figures, this version accepted by Ap
New kindergarten teachers' career development trajectories in China : A problem-solving perspective
Since the 1960s, concerns for beginning teachers have attracted extensive attention. High attrition rates among beginning teachers have been an international challenge, which is costly for a nation's budget. To improve the retention of new teachers, it is imperative to understand what beginning teachers have experienced in their professional practice. This qualitative research examined the career development trajectories of beginning kindergarten teachers in China. The experiences of 23 kindergarten teachers from Nanjing were investigated through semi-structured interviews. Using grounded theory, this research identified four main themes and four career development trajectories. Themes include orientation, mastery, re-examination and self-validation, while career development trajectories reveal that teacher career development is not unilinear, but diverse. These findings are crucial in raising the awareness of researchers and practitioners about the diversities and possibilities of teacher career development trajectories. Further implications for researchers, teacher educators and kindergarten teachers are discussed.The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by MOE (Ministry of Education in China) Project of Humanities and Social Sciences (Grant Number: 17YJA880025), The 13th Five-year Plan for Educational Science in Jiangsu Province (Grant Number: B-a/2016/01/34), and Excellent Preschool Teacher Preparation Program of MOE
Chinese Preschoolers’ Mental Number Line and Mental Number Distance: Valid Characteristics Using Dirichlet Process Gaussian Mixture Model
Clinicopathological analysis of the periprosthetic tissue of revision total hip and knee arthroplasty
Protective Effect of Koumine, an Alkaloid from Gelsemium Sempervirens, on Injury Induced by H2O2 in IPEC-J2 Cells
The efficacy of wechat-based parenting training on the psychological well-being of mothers with children with autism during the COVID-19 pandemic: Quasi-experimental study
10.2196/23917JMIR Mental Health82e2391
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
BACKGROUND: Multiple myeloma (MM) is still incurable and characterized by clonal expansion of plasma cells in the bone marrow (BM). Therefore, effective therapeutic interventions must target both myeloma cells and the BM niche. METHODS: Cell proliferation, drug resistance, and chromosomal instability (CIN) induced by CHEK1 were confirmed by Giemsa staining, exon sequencing, immunofluorescence and xenograft model in vivo. Bone lesion was evaluated by Tartrate-resistant acid phosphatase (TRAP) staining. The existence of circCHEK1_246aa was evaluated by qPCR, Sanger sequencing and Mass Spectrometer. RESULTS: We demonstrated that CHEK1 expression was significantly increased in human MM samples relative to normal plasma cells, and that in MM patients, high CHEK1 expression was associated with poor outcomes. Increased CHEK1 expression induced MM cellular proliferation and evoked drug-resistance in vitro and in vivo. CHEK1-mediated increases in cell proliferation and drug resistance were due in part to CHEK1-induced CIN. CHEK1 activated CIN, partly by phosphorylating CEP170. Interestingly, CHEK1 promoted osteoclast differentiation by upregulating NFATc1 expression. Intriguingly, we discovered that MM cells expressed circCHEK1_246aa, a circular CHEK1 RNA, which encoded and was translated to the CHEK1 kinase catalytic center. Transfection of circCHEK1_246aa increased MM CIN and osteoclast differentiation similarly to CHEK1 overexpression, suggesting that MM cells could secrete circCHEK1_246aa in the BM niche to increase the invasive potential of MM cells and promote osteoclast differentiation. CONCLUSIONS: Our findings suggest that targeting the enzymatic catalytic center encoded by CHEK1 mRNA and circCHEK1_246aa is a promising therapeutic modality to target both MM cells and BM niche. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-021-01380-0
AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
Abstract Background Currently, multiple myeloma (MM) is still an incurable plasma cell malignancy in urgent need of novel therapeutic targets and drugs. Methods Bufalin was known as a highly toxic but effective anti-cancer compound. We used Bufalin as a probe to screen its potential targets by proteome microarray, in which AHSA1 was the unique target of Bufalin. The effects of AHSA1 on cellular proliferation and drug resistance were determined by MTT, western blot, flow cytometry, immunohistochemistry staining and xenograft model in vivo. The potential mechanisms of Bufalin and KU-177 in AHSA1/HSP90 were verified by co-immunoprecipitation, mass spectrometry, site mutation and microscale thermophoresis assay. Results AHSA1 expression was increased in MM samples compared to normal controls, which was significantly associated with MM relapse and poor outcomes. Furthermore, AHSA1 promoted MM cell proliferation and proteasome inhibitor (PI) resistance in vitro and in vivo. Mechanism exploration indicated that AHSA1 acted as a co-chaperone of HSP90A to activate CDK6 and PSMD2, which were key regulators of MM proliferation and PI resistance respectively. Additionally, we identified AHSA1-K137 as the specific binding site of Bufalin on AHSA1, mutation of which decreased the interaction of AHSA1 with HSP90A and suppressed the function of AHSA1 on mediating CDK6 and PSMD2. Intriguingly, we discovered KU-177, an AHSA1 selective inhibitor, and found KU-177 targeting the same site as Bufalin. Bufalin and KU-177 treatments hampered the proliferation of flow MRD-positive cells in both primary MM and recurrent MM patient samples. Moreover, KU-177 abrogated the cellular proliferation and PI resistance induced by elevated AHSA1, and decreased the expression of CDK6 and PSMD2. Conclusions We demonstrate that AHSA1 may serve as a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma